Comparison of the metabolic effects of long-term treatment with pindolol or atenolol by hypertensive patients

1988 ◽  
Vol 1 (5) ◽  
pp. 549-551 ◽  
Author(s):  
A. Lehtonen
1988 ◽  
Vol 6 (11) ◽  
pp. 925-930 ◽  
Author(s):  
Antoon Amery ◽  
Willem Birkenh??ger ◽  
Christopher Bulpitt ◽  
Denis Clement ◽  
Peter de Leeuw ◽  
...  

2016 ◽  
Vol 40 (6) ◽  
pp. 310-314 ◽  
Author(s):  
Laura Chiwanda ◽  
Matthew Cordiner ◽  
Anne T. Thompson ◽  
Polash Shajahan

Aims and methodTo discern changes in body mass index (BMI) in patients on long-term antidepressant treatment in a general practice population and establish BMI changes in patients with and without a diagnosis of diabetes. We used a retrospective observational method and identified patients on four antidepressants of interest. We excluded those who did not have start and current BMI readings within the past 3 years and noted whether or not patients had a diagnosis of diabetes.ResultsLong-term treatment with citalopram, fluoxetine, mirtazapine and sertraline was associated with increased BMI in two-thirds of patients. There was reduction in BMI in patients with diabetes and an increase in BMI for patients who did not have diabetes.Clinical implicationsAwareness of environmental factors and their impact on individuals is important. Medication is not the only cause of abnormal metabolic effects. Overall monitoring of physical health is important in all groups of patients.


Diabetes Care ◽  
1987 ◽  
Vol 10 (6) ◽  
pp. 71-78 ◽  
Author(s):  
L. Groop ◽  
P. H. Groop ◽  
S. Stenman ◽  
C. Saloranta ◽  
K. J. Totterman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document